Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis

BACKGROUND: In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Health GmbH) against larval stages and immature adults of Aelu...

Descripción completa

Detalles Bibliográficos
Autores principales: Heuer, Lea, Petry, Gabriele, Pollmeier, Matthias, Schaper, Roland, Deuster, Katrin, Schmidt, Holger, Blazejak, Katrin, Strube, Christina, Di Cesare, Angela, Traversa, Donato, Schnyder, Manuela, McKay-Demeler, Janina, von Samson-Himmelstjerna, Georg, Mangold-Gehring, Sandra, Böhm, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017503/
https://www.ncbi.nlm.nih.gov/pubmed/32051008
http://dx.doi.org/10.1186/s13071-020-3937-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017503/
https://www.ncbi.nlm.nih.gov/pubmed/32051008
http://dx.doi.org/10.1186/s13071-020-3937-2

Ejemplares similares